Induction of antitumor immunity by dendritic cells loaded with membrane-translocating mucin 1 Peptide antigen (Q34518328)

2 August 2017

title

Induction of antitumor immunity by dendritic cells loaded with membrane-translocating mucin 1 Peptide antigen (English)

1 reference

2 August 2017

1 reference

Saho Kobukai

1

1 reference

2 August 2017

Gert-Jan Kremers

2

1 reference

2 August 2017

Jared G Cobb

3

1 reference

2 August 2017

Richard Baheza

4

1 reference

2 August 2017

Jingping Xie

5

1 reference

2 August 2017

Alex Kuley

6

1 reference

2 August 2017

Meiying Zhu

7

1 reference

2 August 2017

Wellington Pham

8

1 reference

2 August 2017

publication date

1 February 2011

1 reference

2 August 2017

published in

Translational Oncology

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

1-8

1 reference

Tumor Antigen Presentation by Dendritic Cells

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Magnetic nanoparticles for imaging dendritic cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Tracking the migration of dendritic cells by in vivo optical imaging

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Immune responses in the draining lymph nodes against cancer: implications for immunotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Synthesis and application of a water-soluble near-infrared dye for cancer detection using optical imaging

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Developing a peptide-based near-infrared molecular probe for protease sensing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

7 July 2018

Epithelial mucin genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

In vivo imaging of tumor response to therapy using a dual-modality imaging strategy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Enhancing membrane permeability by fatty acylation of oligoarginine peptides

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Increased expression of MUC1 in advanced pancreatic cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

An azulene dimer as a near-infrared quencher

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3026404

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

27 October 2018

1 reference

12 December 2020

Dendritic cells: therapy and imaging

1 reference

12 December 2020

Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer

1 reference

12 December 2020

Transcriptional regulation of the MUC1 mucin gene in colon carcinoma cells by a soluble factor. Identification of a regulatory element

1 reference

12 December 2020

A short synthetic peptide (DTRPAP) induces anti-mucin (MUC-1) antibody, which is reactive with human ovarian and breast cancer cells

1 reference

12 December 2020

Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells

1 reference

12 December 2020

Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred

1 reference

12 December 2020

Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen

1 reference

12 December 2020

Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model

1 reference

12 December 2020

MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

1 reference

12 December 2020

Dendritic cell-based immunotherapy for prostate cancer

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Identifiers

DOI

10.1593/TLO.10166

1 reference

2 August 2017

1 reference

2 August 2017

1 reference